The report "Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022", The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).
Objectives of the Study:
# To define, measure, and describe the global human liver model market by type and region.
# To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities).
# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
# To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW.
The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468
Animal models accounted for the largest share of the market in 2017
The human liver models market is segmented on the basis of type into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. In 2017, the animal models segment accounted for the largest share of the global market.
The growth in the biosimilars market is expected to boost the preclinical market as the development of biosimilars and biopharmaceuticals requires an understanding of the mechanism of action, quantification of pharmacological effects, and interpretation of toxicological data. Preclinical research also helps in securing a clear definition of targets.
Target Audience:
# Pharmaceutical and biotechnology companies
# Chemical companies
# Cosmetic product manufacturers, suppliers, and distributors
# Healthcare providers and diagnostic laboratories
# Manufacturers of 3D Cell Culture products
# Food & beverage manufacturers
# Contract research organizations (CROs)
# Research institutes/universities
# Research and consulting firms
# Venture capitalists
Moreover, as the patents for many blockbuster drugs are set to expire by 2020, the demand for biosimilars and preclinical services is likely to increase. The rising demand for preclinical services, in turn is expected to drive the demand for animal models.
North America held the largest share of the market in 2017
In 2017, North America accounted for the largest share of the human liver models market, followed by Europe.
The market for human liver models in this region is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, favorable government initiatives, growing incidence of NAFLD, and unavailability of livers for transplantation, increased research spending, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468
Major Leaders of the Industry:
The major players in the global human liver model market are Emulate (US), Ascendance Bio (US), HìREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).
CN Bio held the leading position in the global liver-on-a-chip market in 2016. The company offers its products and services for drug discovery and drug safety programs. To enhance its production capabilities and applications, the company focuses on adopting inorganic strategies such as collaborations and agreements. Over the last three years, CN Bio has been a part of six such initiatives that helped the company enhance its presence in this market.
The global liver 3D bioprinting market was dominated by Organovo Holdings, Inc. (US). With its broad product portfolio, Organovo Holdings, Inc. held the leadership position in the global 3D bioprinting market for liver in 2016. Its large market share is attributed to its robust 3D bioprinting portfolio. In addition, the company is focusing on various strategies to expand its product offerings and increase its visibility in the 3D bioprinting market. In line with this, the company has collaborated with various research organizations and pharmaceutical companies for developing novel products.
Rising need for early drug toxicity detection, increasing funding for research and initial capital investments to develop organoids, and rising prevalence of liver disorders are some key factors augmenting market growthHuman Liver Models Market size: USD 2.0 Billion in 2020, Market Growth: CAGR of 13.9%, Market Trends: Increasing research on liver organoids The Human Liver Models Market report is an all-encompassing report published by Reports and Data that represents data in a graphical representation such as graphs, charts, tables, and figures to offer easy comprehension of the market scenario.
The report provides an industry-wide examination of the Human Liver Models market with regards to the impact of the COVID-19 pandemic and its impact on the key segments and sub-segments.
The pandemic has dynamically altered the market landscape and has brought changes in the demands and trends in the industry.
The report studies in detail these changes to offer a growth forecast in a post-COVID scenario.The report studies dynamic market elements such as drivers, restraints, challenges, threats, opportunities, and growth prospects, among others.
It provides critical insights into market share, market size, market growth, revenue growth, and comprehensive industrial chain analysis.
The detailed analysis of the competitive landscape offers a competitive advantage to the reader and helps them gain a better understanding of the industry.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4015Key market players analyzed in the report are:Emulate Inc., Ascendance Bio, Organovo Holdings Inc., CN Bio Innovations, Cyfuse Biomedical, HìREL, InSphero, BioIVT, and Mimetas.Furthermore, it offers a detailed analysis of the competitive landscape of the market with insightful data on recent trends, technological developments, product advancements, methodologies, and strategic business decisions such as mergers and acquisitions, joint ventures, collaborations, and product launches, among others.It further offers critical insights on the regional bifurcation of the market with regards to market scope, market size, market share, revenue generation, production and consumption ratio, supply and demand ratio, and analysis of the key players operating in those regions.
Liver is one of the most important and sensitive part of a human body that’s why we are proud to announce the list of Super Seven Foods for a Healthy Liver.
It has also been considered as the most complicated body part where there are more than fifty thousand chemicalContinue Reading
Best Things to Save your Liver you should Drink Raisin Water with taken Some Dry Fruit
We often take our livers as a right by intense harmful substances in our bodies like alcohol.
there's even a condition that is thought as Non-Alcoholic disease that may be caused by intense product with superimposed deep-fried foods, sugar, excess salt and pork.
So, what’s the large secret behind dried fruit water?
specialists believe that drinking dried fruit water stimulates sure organic chemistry processes within the liver, that facilitate it a lot of effectively take away toxins from your blood.
Liver and urinary organ square measure one in all gift in your body, that helps cleanse your blood, removes all the toxins and serious metals gift within the body.
Best Things to Save your Liver you should Drink Raisin Water with taken Some Dry Fruit
We often take our livers as a right by intense harmful substances in our bodies like alcohol.
there's even a condition that is thought as Non-Alcoholic disease that may be caused by intense product with superimposed deep-fried foods, sugar, excess salt and pork.
So, what’s the large secret behind dried fruit water?
specialists believe that drinking dried fruit water stimulates sure organic chemistry processes within the liver, that facilitate it a lot of effectively take away toxins from your blood.
Liver and urinary organ square measure one in all gift in your body, that helps cleanse your blood, removes all the toxins and serious metals gift within the body.
